Regenerative medicine clinical readiness

Regenerative medicine, poised to transform 21st century healthcare, has aspired to enrich care options by bringing cures to patients in need. Science-driven responsible and regulated translation of innovative technology has enabled the launch of previously unimaginable care pathways adopted prudently for select serious diseases and disabilities. The collective resolve to advance the design, manufacture and validity of affordable regenerative solutions aims to democratize such health benefits for all. The objective of this Review is to outline the framework and prerequisites that underpin clinical readiness of regenerative care. Integrated research and development, specialized workforce education and accessible evidence-based practice implementation are at the core of realizing an equitable regenerative medicine vision.

Automated summary

Regenerative medicine aims to provide more care options for patients in need through technological innovation, helping them to get cured. Through responsible and regulated translation, regenerative medical technology is applied to the treatment of serious diseases and disabilities. By advancing the design, manufacture, and effectiveness of regenerative solutions, the goal is to democratize health benefits for all.